Blood test patterns in fatty liver disease
This study looks at blood test results in people with fatty liver disease to find common blood abnormalities. It may help doctors better understand and manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a fatty liver disease diagnosis confirmed by a FibroScan test.
- Your complete blood count (CBC) results must be available.
- You must not have liver disease caused by alcohol, viruses, or autoimmune conditions.
- You must not have other chronic liver diseases or known causes of fatty liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study checks if a simple blood test (LIVERFASt) can accurately measure liver fat and scarring compared to MRI. It may help patients avoid more invasive tests in the future.
This study tests a new blood test to help diagnose fatty liver disease and liver fibrosis. It aims to see how well the test works compared with a liver biopsy. Your participation could help improve diagnosis for others.
This study explores if a new ultrasound technique can detect fatty liver disease in children. It aims to find a simpler, safer way to check liver health without needing an MRI or biopsy.
Hear when a new MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.